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Whereas there are numerous studies on unintentional weight loss (UWL), these have been
limited by small sample sizes, short or variable follow-up, and focus on older patients.
Although some case series have revealed that malignancies escaping early detection and
uncovered subsequently are exceptional, reported follow-ups have been too short or
unspecified and necropsies seldom made. Our objective was to examine the etiologies,
characteristics, and long-term outcome of UWL in a large cohort of outpatients.
Methods
We prospectively enrolled patients referred to an outpatient diagnosis unit for evaluation of
UWL as a dominant or isolated feature of disease. Eligible patients underwent a standard
baseline evaluation with laboratory tests and chest X-ray. Patients without identifiable
causes 6 months after presentation underwent a systematic follow-up lasting for 60 further
months. Subjects aged65 years without initially recognizable causes underwent an oral
cavity examination, a videofluoroscopy or swallowing study, and a depression and cognitive
assessment.
Results
Overall, 2677 patients (mean age, 64.4 [14.7] years; 51% males) were included. Predomi-
nant etiologies were digestive organic disorders (nonmalignant in 17% and malignant in
16%). Psychosocial disorders explained 16% of cases. Oral disorders were second to non-
hematologic malignancies as cause of UWL in patients aged65 years. Although 375
(14%) patients were initially diagnosed with unexplained UWL, malignancies were detected
in only 19 (5%) within the first 28 months after referral. Diagnosis was established at autopsy
in 14 cases.
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Conclusion
This investigation provides new information on the relevance of follow-up in the long-term
clinical outcome of patients with unexplained UWL and on the role of age on this entity.
Although unexplained UWL seldom constitutes a short-term medical alert, malignancies
may be undetectable until death. Therefore, these patients should be followed up regularly
(eg yearly visits) for longer than reported periods, and autopsies pursued when facing
unsolved deaths.
Introduction
Owing to the broad differential diagnosis and the lack of standardized guidelines or externally
validated clinical prediction rules, unintentional weight loss (UWL) constitutes a diagnostic
challenge for the clinician. While clinical judgment remains ever essential, the workup needs
to be individualized and primarily based on medical history and physical examination findings
[1–5]. However, extensive, costly and invasive investigations are sometimes performed so as to
not missing an underlying malignancy [1,2].
Although numerous, yet small, studies have investigated UWL, clinical settings, popula-
tions, and definition criteria vary considerably [2–9]. The rate of diagnosis after initial workup
(the content of which differs by series) ranges from 33 to 60% [2–8]. In general, malignancies,
nonmalignant organic disorders, and psychiatric disorders constitute the main etiologic
groups of UWL [1,10–14]. Social factors are occasionally considered a separate group or, more
commonly, included in the group of psychiatric causes (so-called psychosocial disorders)
[10,11,15–17]. Unexplained UWL is comparatively common, accounting for 11–28% of cases
[2–9]. Reports have frequently concentrated on elders, in whom UWS is quite prevalent and
somewhat behaves as a distinct clinical entity [10,11,15–18]. Because of complex multifactorial
and interrelated causes, UWL in older subjects poses a harder diagnostic challenge.
While the largest prospective studies on UWL have mainly admitted patients for workup
[2,8,19], the impact of the recent economic regression on health systems has driven some
efforts to reduce the huge expenses incurred by hospitalization [20–24]. In Spain, patients
needing workup for potentially serious diseases such as UWL have been traditionally admitted
in acute hospitals without needing actual therapy [23,25–27]. Whilst inappropriate use of hos-
pital beds surpasses 20% through diverse specialties in Europe, admission for workup is one of
the commonest reasons for inappropriate hospitalizations [28,29]. Deficiencies at several levels
of the Spanish healthcare system prompted the creation of alternatives to hospitalization,
exemplified by hospital-based outpatients’ quick diagnosis units (OQDUs) [23,25,30–33].
Reported advantages over hospitalization are numerous: besides ensuring a time-to-diagnosis
similar to the length-of-stay for the same evaluable condition, these clinics decrease emergency
department referrals from primary healthcare centers and ease overcrowding, are associated
with higher scores of patient reported satisfaction than inpatients, and are significantly cost-
saving [31,34–42]. Malignancies constitute the most frequent diagnosis in Spanish OQDUs
(18–30%) [35,42].
Since cancer may be the cause of UWL in some patients presenting with few or no accom-
panying symptoms [2,3,19], a swift workup can be crucial. Because a normally acceptable
physical performance argues against hospitalization of subjects referred for UWL investiga-
tion, OQDUs appear a suitable setting for their evaluation. Yet their significance for UWL
has not been reported to date. The purpose of this study was to investigate the etiologies,
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characteristics, and long-term clinical outcomes of UWL in a large cohort of patients referred
to the OQDU of a tertiary university hospital, the largest thus far reported.
Materials and methods
Setting
The OQDU is located in the adult day care center of the Hospital Clı́nic of Barcelona. With a
reference population of about 550,000, most patients are referred to this outpatient unit from
15 primary healthcare centers and the hospital emergency department. Referral criteria, evalu-
able disorders (which include UWL), characteristics, and functioning of OQDU have been
previously reported [36,39]. The general status of evaluable patients must be well-enough to
allow them to travel to hospital, then back to home, for visits and investigations.
Terms and definitions used in this study
Unintentional weight loss. Clinical entity whereby the patient does not purposefully set
out to lose weight for any reason and when weight loss as a consequence of advanced chronic
diseases or their treatments (eg diuretics for heart failure) is excluded [1]. Definition criteria
were numerical verification of>5% reduction in usual body weight over the preceding 6–12
months, or, for subjects without numerical documentation, at least two of the following: evi-
dence of change in clothing size, corroboration of the reported weight loss by a relative or
friend, and ability to give a numerical estimate of the amount of weight loss [4].
Unintentional weight loss of known origin. When a previously reported cause of UWL
was identified.
Unexplained unintentional weight loss. When a cause of UWL was not identified
after an initial clinical evaluation and workup and it remained unknown 6 months after
presentation.
Intentional weight loss. When the patient did purposefully set out to lose weight through
dieting, exercise, self-induced vomiting, use of medications (eg anorexigenic drugs, diuretics,
or laxatives), or following bariatric surgery [14].
Cachexia syndrome. Clinical entity whereby the patient has lost >5% of weight in <12
months, has an advanced chronic illness (heart failure, respiratory disease [mainly chronic
obstructive pulmonary disease and interstitial lung disease], and kidney disease), and has at
least three of the following: anorexia, fatigue, decreased muscle strength, low fat-free mass
index, and abnormal laboratory tests including increased inflammatory markers, low serum
albumin, and anemia [43].
Study design and population
In this prospective observational study, consecutive patients referred to OQDU for evaluation
of UWL were assessed for eligibility. Patients were referred from the emergency department
and 15 primary healthcare centers between August 2008 and February 2011. The research eth-
ics committee of the Hospital Clı́nic, which operated as a central ethics review board for the
primary healthcare centers via specific agreements, approved the study. Participants were
required to approve a written informed consent for their enrollment and the ethical guidelines
of the Declaration of Helsinki were observed. Inclusion criteria were age18 years, definition
criteria of UWL [4], and UWL as a dominant or isolated feature of disease. Exclusion criteria
were intentional weight loss [14], cachexia syndrome [43], evolving known malignancy, eating
disorders, hospital admission within last 3 months, flare-ups of chronic diseases, and poorly
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controlled chronic pain syndromes. Patients in whom UWL resolved before the first outpa-
tient visit and those lost to follow-up or dead before a diagnosis was made were also excluded.
Evaluation
Baseline evaluation. At first OQDU consultation, a consultant internist asked patients
about past and present medical history and performed an exhaustive physical examination.
Attention was paid to clinical presentation, accompanying symptoms, estimated amount of
weight loss (percentage and Kg over the preceding 6–12 months), use of prescribed, over-the-
counter and illicit drugs, comorbidities (evaluated with the age-adjusted Charlson index
[44,45]), psychosocial issues, and, especially in patients aged65 years, presence of dental
pain, dry mouth and difficulty swallowing (herein referred to as oral problems or disorders),
cognitive impairment/dementia, and disability/immobility. When there were doubts about the
presence of cognitive impairment, a relative/caregiver was asked to provide information.
Although initial tests were carried out as appropriate according to clinical evaluation and
patient age, minimal investigations included chest X-ray and standard laboratory tests. These
included C-reactive protein, erythrosedimentation rate, hemogram (total leukocytes, manual
white blood cell count, hemoglobin, hematocrit, reticulocytes, red blood cell indices, and plate-
let count), and serum levels of ferritin, glucose, cholesterol, aminotransferases, alkaline phos-
phatase, γ-glutamyl transpeptidase, total bilirubin, lactate dehydrogenase, total proteins,
albumin, creatinine, and electrolytes (sodium, potassium, and calcium). Protein electrophore-
sis, estimated glomerular filtration rate, urinalysis, and fecal occult blood were also ordered.
Further investigations. Other examinations were ordered according to the results of
baseline evaluation and assessment of patient outcome during successive visits (eg additional
laboratory tests, imaging studies such as abdominal ultrasound, computed tomography and
FDG-PET scanning, endoscopies, and biopsy/cytology studies). Patients aged65 years with
unexplained UWL after the first evaluation underwent an examination of the oral cavity.
Potential depression and cognitive problems were assessed with the geriatric depression scale
(short form) [46] and the Mini-Cognitive Assessment Instrument (Mini-Cog) [47], respec-
tively. Uncertain difficulty swallowing/dysphagia was evaluated with videofluoroscopy, or, if
unfeasible, a swallowing study [48]. The latter is an adaptation of a validated procedure in
which subjective bedside assessment of swallowing is combined with concurrent monitoring
of oxygen saturation [48,49].
Causes of unintentional weight loss
The individual causes of UWL were coded post hoc according to the International Statistical
Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10 Version:
2015) [50]. Specifically, a list was first created that included all individual diagnosis reported to
cause UWL. Each listed disorder was then searched in the ICD-10 list and codified accord-
ingly. When any disorder was not termed as such in the ICD-10 list, the equivalent disorder
and the corresponding code were used. For instance, diagnosis ‘oral, swallowing, and dental
problems’ does not exist as such in the ICD-10 list. However, codes K08.9, K11.7, R13, and
R43.8 in the list correspond to ‘disorder of teeth and supporting structures, unspecified’, ‘dis-
turbances of salivary secretion’, ‘dysphagia (Incl.: difficulty in swallowing)’, and ‘other and
unspecified disturbances of smell and taste’, respectively. Furthermore, to ensure accuracy in
the validation of the codification process, three coauthors (EM, OE, and PM) independently
performed this process for all the individual diagnoses. Any discrepancy was eventually
resolved by consensus with the senior author.
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In line with earlier reports [1–3,8,9], albeit with some variation, three main etiologic groups
were established: malignancies, nonmalignant organic disorders, and psychosocial disorders.
Follow-up
All patients were initially followed-up for a minimum of 1 to a maximum of 18 months or
death.
Unexplained unintentional weight loss. Patients with unexplained UWL were followed-
up for localizing symptoms or signs suggesting a diagnosis, weight changes, and survival.
Patients were firstly reevaluated through successive visits at 1, 3, and 6 months after presenta-
tion. When the cause remained unknown after the initial 6 months’ period, reevaluation con-
tinued by further visits at 9, 12, and 18 months or, if the patient missed the appointment, by
phone calls to them (or their relatives) and the physicians at primary healthcare centers in
charge of them. If the etiology still remained unknown 18 months after presentation, the pri-
mary healthcare centers’ physicians and the patients (or their relatives) were interviewed by
the OQDU physicians once every 3 months to a maximum of 4 additional years or death.
Patients’ electronic health records—recorded in the integrated computerized system of the
hospital and the primary healthcare centers—were also accessed and examined to obtain fol-
low-up clinical data.
Unintentional weight loss of known origin. Patients were followed-up after diagnosis for
weight changes and survival in each etiologic group. Electronic medical records were also
accessed to obtain follow-up information. If it was insufficient, the patients (or their relatives)
or the physicians in charge of them were contacted.
Database
Besides the aforementioned data, referral sources, demographic and epidemiological data,
socioeconomic status (measured by education and income), smoking habit, alcohol consump-
tion, type and number of investigations performed, time-to-diagnosis (from first OQDU visit
to diagnosis), and hospitalizations were prospectively tabulated in a database.
Statistical analysis
The chi-square test or the Fisher’s exact test, as appropriate, was used to compare categorical
data, which are expressed as absolute frequencies (%). The t-test was used to compare continu-
ous variables with a normal distribution, which are expressed as means with standard devia-
tions (SD). When appropriate, the nonparametric Mann-Whitney U test was used to compare
continuous variables with skewed distributions. Since it was a prospective study where all data
were meticulously collected and registered, the amount of missing data was expected to be
irrelevant. However, any type of missing items was included in the study analysis. Statistical
significance was established at .05. Analyses were done with SPSS software (version 21.0)
(SPSS, Chicago, USA).
Results
General characteristics of study population
Among 3169 initially eligible patients, 574 were excluded, leaving 2677 for the final analysis
(Fig 1). Fifty-one percent were males and mean age was 64.4 (14.7) years. The estimated weight
loss was 11.9 (6.7) percent or 8.3 (4.5) Kg. Referral sources, socioeconomic status, smoking
and drinking status, and mean time-to-diagnosis are shown in Table 1. There were minimal
missing data on the categorical variables educational level and monthly income (0.001 and
Characteristics and outcomes of unintentional weight loss
PLOS ONE | https://doi.org/10.1371/journal.pone.0175125 April 7, 2017 5 / 20
<1%, respectively) and complete data on other variables. The relative percentages of the items
of these categorical variables were calculated according to the total number of patients without
missing data (see footnote of Table 1).
Causes of unintentional weight loss
Although the cause of UWL was unknown in 582 patients after the first outpatient visit, evalu-
ation within 6 months after presentation disclosed an etiology in 207 including malignancies
in 27, digestive disorders in 13, polyarteritis nodosa in 3, UWL as a side effect of drugs (herein
referred to as drug-induced UWL) in 24, and psychosocial disorders in 140. Thus, 375 patients
remained without diagnosis and were categorized with unexplained UWL (14% of patients)
and the rest (86%) were categorized with UWL of known origin. Specific causal disorders and
ICD-10 codes matched in 96% of cases after an independent assessment by three investigators.
Agreement was reached in all cases after discussion with the leading investigator. For the pur-
pose of the analyses, 4 main groups of UWL were established: nonmalignant organic disorders
(n = 991 [37%]), malignancies (n = 883 [33%]), psychosocial disorders (n = 428 [16%]), and
unexplained UWL (n = 375 [14%]) (Fig 1 and Tables 1 and 2).
Malignancies. Manifestations leading to a diagnosis within the first 6 months in the 27
abovementioned cancer patients included, among others, abdominal pain, fever, and periph-
eral lymphadenopathy. Out of 27, 11 had pancreatic cancer and 9 had lymphoma. Overall,
digestive cancers (n = 415 [47% of malignancies]) prevailed over the rest of cancers. Main spe-
cific cancers were pancreatic (19% of malignancies), lung (17%), lymphoma (11%), and kid-
ney, ureteral, and bladder cancers (10% together) (Table 2).
Nonmalignant organic disorders. Most common disorders were digestive (n = 450 [45%
of nonmalignant organic disorders]), with oral disorders making up 31% of digestive causes.
Endocrine, infectious, nervous system and systemic autoimmune diseases, and drug-induced
UWL were also relatively frequent (Table 2).
Fig 1. Flowchart of enrollment of patients with unintentional weight loss.
https://doi.org/10.1371/journal.pone.0175125.g001
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Psychiatric disorders. Psychiatric causes were diagnosed in 374 (14%) patients, most
notably depression (7% of UWL cases). Social factors accounted for 2% of UWL cases, mostly
comprising problems related to housing and economic circumstances (Table 2).
Characteristics according to patient groups. Patients with malignancies were older,
more often males and active smokers, and had a greater weight loss than patients from the
other groups. While patients with nonmalignant organic disorders were younger than other
patients, those with psychosocial disorders were more often females and had a lower socioeco-
nomic status and a smaller amount of weight loss than others. Patents with malignancies and
nonmalignant organic disorders were more likely to have accompanying symptoms and
abnormalities on physical examination, laboratory tests and chest X-ray and less often had a
Table 1. General characteristics of study patients.
Characteristic Patients
(N = 2677)
Sources of referral, n (%)
Emergency department 1660 (62)
Primary healthcare centers 1017 (38)





Educational level, n (%)
No schooling 252 (9)
Primary or lower secondary 1043 (39)
Upper secondary or professional training 949 (35)
University 430 (16)





Active smoker, n (%) 773 (29)
Active drinker, n (%) 570 (21)
Estimated weight loss (% over 6–12 months), mean (SD) 11.9 (6.7)
Estimated weight loss (Kg over 6–12 months), mean (SD) 8.3 (4.5)
Unintentional weight loss of known origin, n (%) 2302 (86)
Malignant disorders 883 (33)
Nonmalignant organic disorders 991 (37)
Psychosocial disorders 428 (16)
Initially unexplained unintentional weight loss, n (%) † 375 (14)
Time-to-diagnosis (days), mean (SD) ‡ 14.0 (3.6)
* Self-reported household income, including all income components received by any household member,
after tax subtraction.
† Patients without an identifiable cause of unintentional weight loss 6 months after presentation.
‡ For malignant disorders, nonmalignant organic disorders, and psychosocial disorders.
Missing data: variables ‘no schooling’ (n = 3) and monthly incomes of’ ‘901–1200’ (n = 8) and of ‘1201–1800’
(n = 12).
https://doi.org/10.1371/journal.pone.0175125.t001
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Table 2. Specific causes of unintentional weight loss.*
Cause Patients †
(N = 2677)
Malignant disorders 883 (33)
Esophagus, stomach, colon, rectum, pancreas, liver cell carcinoma, and intrahepatic bile duct
carcinoma [C15, C16, C18, C20, C25, C22.0, C22.1]
415 (47)
Breast [C50] 27 (3)
Cervix uteri, endometrium, and ovary [C53, C54.1, C56] 35 (4)
Prostate [C61] 53 (6)
Kidney, renal pelvis, ureter, and bladder [C64, C65, C66, C67] 88 (10)
Bronchus and lung [C34] 150 (17)
Hodgkin lymphoma and non-Hodgkin lymphoma, unspecified [C81, C85.9] 97 (11)
Malignant neoplasm, primary site unknown, so stated [C80.0] 18 (2)
Nonmalignant organic disorders 991 (37)
Digestive disorders 450 (45)
Gastric and duodenal ulcers [K25, K26] 81 (18)
Oral, swallowing, and dental problems [K08.9, K11.7, R13, R43.8] 141 (31)
Crohn disease [regional enteritis] and ulcerative colitis [K50, K51] 44 (10)
Indeterminate colitis and other specified noninfective gastroenteritis and colitis [K52.3, K52.8] 97 (22)
Chronic vascular disorders of intestine [K55.1] 24 (5)
Celiac disease, pancreatic steatorrhea, and intestinal malabsorption, unspecified [K90.0,
K90.3, K90.9]
63 (14)
Endocrine disorders 139 (14)
Thyrotoxicosis [hyperthyroidism] [E05] 64 (46)
Subacute thyroiditis [E06.1] 11 (8)
Type 1 and type 2 diabetes mellitus [E10, E11] 54 (39)
Primary hyperparathyroidism [E21.0] 10 (7)
Infectious diseases 119 (12)
Primary respiratory tuberculosis, tuberculous pleurisy and tuberculosis of intrathoracic lymph
nodes, without mention of bacteriological or histological confirmation, and tuberculous
peripheral lymphadenopathy [A16.7, A16.5, A16.3, A18.2]
46 (39)
Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases,
malignant neoplasms, and wasting syndrome [B20, B21, B22.2]
26 (22)
Other gastroenteritis and colitis of infectious and unspecified origin [A09] 45 (38)
Acute and subacute infective endocarditis [I33.0] 2 (2)
Nervous system diseases 80 (8)
Stroke, not specified as hemorrhage or infarction [I64] 46 (58)
Parkinson disease [G20] 30 (38)
Motor neuron disease [G12.2] 4 (5)
Respiratory diseases 20 (2)
Interstitial pulmonary disease, unspecified, and other interstitial pulmonary diseases with
fibrosis [J84.9, J84.1]
4 (20)
Pleural effusion, not elsewhere classified, and pyothorax without fistula [J90, J86.9] 14 (70)
Abscess of lung without pneumonia [J85.2] 2 (10)
Systemic autoimmune diseases 89 (9)
Polymyalgia rheumatica and giant cell arteritis with polymyalgia rheumatica [M35.3, M31.5] 56 (63)
Polyarteritis nodosa [M30.0] 9 (10)
Systemic lupus erythematosus with organ or system involvement and rheumatoid arthritis,
unspecified [M32.1†, M06.9]
24 (27)
Kidney and ureteral diseases 40 (4)
(Continued)
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normal baseline evaluation than patients with psychosocial disorders and those with unex-
plained UWL. Time-to-diagnosis in the former two groups was statistically longer that in
patients with psychosocial disorders. However, this had a minimal, if any, clinical relevance
since mean differences were only 2.3 and 3.1 days, respectively (Table 3).
Characteristics according to age
When comparing patients aged<65 years (n = 1258) to those aged65 years (n = 1419), sev-
eral significant differences were observed (Table 4). Older subjects were more likely than their
younger counterparts to be males and to have more comorbidities and more weight loss but
were less often diagnosed with UWL of known origin (83 vs. 89%). Malignancies in general,
and digestive and other nonhematologic malignancies in particular, were more prevalent in
older patients, whereas hematologic malignancies prevailed in younger subjects. Oral disor-
ders, stroke, Parkinson disease, dementia, polymyalgia rheumatica with/without giant-cell
arteritis, and drug-induced UWL were more common in older patients. In contrast, endocrine




Rapidly progressive nephritic syndrome, chronic nephritic syndrome, and nephrotic syndrome
[N01, N03, N04]
12 (30)
Nonobstructive reflux-associated chronic pyelonephritis, chronic obstructive pyelonephritis,
and other andunspecified hydronephrosis [N11.0, N11.1, N13.3]
28 (70)
Unspecified adverse effect of drug or medicament [T88.7] ‡ 54 (5)
Psychosocial disorders 428 (16)
Depressive episode [F32] 180 (42)
Somatoform disorders, other anxiety disorders, and obsessive-compulsive disorder [F45, F41,
F42]
122 (29)
Bipolar affective disorder and schizophrenia [F31, F20] 21 (5)
Mental and behavioral disorders due to use of alcohol, opioids, cocaine, and multiple drug use
and use of other psychoactive substances [F10, F11, F14, F19]
4 (1)
Dementia in Alzheimer disease, unspecified, vascular dementia, unspecified, and unspecified
dementia [F00.9*, F01.9, F03]
47 (11)
Problems related to housing and economic circumstances [Z59] 30 (7)
Problems related to social environment including social exclusion and rejection, and neglect
and abandonment [Z60, Y06]
18 (4)
Immobility and limitation of activities due to disability [R26.3, Z73.6] 6 (1)
Initially unexplained unintentional weight loss 375 (14)
* Causes are categorized according to the International Statistical Classification of Diseases and Related
Health Problems 10th Revision (ICD-10 Version: 2015) [50].
† Meaning of the percentages (numbers in parentheses) listed in the table: percentages in main groups
(malignant, nonmalignant organic, and psychosocial disorders) are relative to the entire sample size;
percentages in individual malignant disorders and in individual psychosocial disorders are relative to the total
number of malignant disorders and the total number of psychosocial disorders, respectively; percentages in
the main subgroups of nonmalignant organic disorders (ie digestive, endocrine, infectious nervous system,
respiratory, systemic autoimmune, and kidney and ureteral disorders as well as adverse effect of drug) are
relative to the total number of nonmalignant organic disorders; and percentages in the individual conditions
of each subgroup n of nonmalignant organic disorders are relative to the total number of each subgroup.
‡ Formerly reported prescription, over-the-counter, and illicit drugs accounting for unintentional weight loss.
https://doi.org/10.1371/journal.pone.0175125.t002
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disorders prevailed in younger patients (Table 4). In addition to educational level and monthly
income, there was a minimal rate of missing data on the variable age-adjusted Charlson
comorbidity index (<1% in both patients aged<65 and65 years) (see footnote of Table 4).
Clinical outcome of patient groups
Patients were initially followed-up for a mean of 14.5 (7.6) months (range, 1–18 months).
Table 5 displays the mean follow-up times and mortality rates in each group. A total of 712
(27% of study population) patients died during the initial follow-up. Cancer patients had the
highest mortality rate (69 vs. 5–6% in other groups). Survivors in each group were categorized
according to weight changes (decreased, increased, or stable). Decreasing weight was substan-
tially more frequent in survivors with malignancies (66%) than in the rest and it was also more
common in survivors with nonmalignant organic disorders (10%) than in unexplained UWL
(6%) and psychosocial disorders (3%). Increasing weight was more common in patients with
Table 3. Characteristics of patient groups.
Characteristic MDs a NMDs b PSDs c UE d P value
(n = 883) (n = 991) (n = 428) (n = 375) a vs. b a vs. c a vs. d b vs. c b vs. d c vs. d
Age (years), mean (SD) 69.1 (12.2) 60.2 (12.8) 62.7 (11.0) 65.1 (10.4) < .001 < .001 < .001 < .001 < .001 < .001
Sex, n (%) < .001 < .001 < .001 .101 .044 < .001
Females 362 (41) 525 (53) 235 (55) 184 (49)
Males 521 (59) 466 (47) 193 (45) 191 (51)
SE status
Education, n (%) .048 < .001 .123 < .001 .102 < .001
No schooling 86 (10) 68 (7) 64 (15) 34 (9)
Primary/lower secondary 353 (40) 347 (35) 205 (48) 138 (37)
Upper secondary/PT 309 (35) 377 (38) 124 (29) 139 (37)
University 133 (15) 198 (20) 35 (8) 64 (17)
Monthly income (Euros), n (%) < .001 .112 < .001 < .001 .127 < .001
900 115 (13) 69 (7) 60 (14) 30 (8)
901–1200 296 (34) 255 (26) 157 (37) 101 (27)
1201–1800 313 (36) 382 (39) 141 (33) 148 (40)
>1800 150 (17) 277 (28) 69 (16) 94 (25)
Active smoker, n (%) 291 (33) 277 (28) 111 (26) 94 (25) < .001 < .001 < .001 .113 .100 .234
Active drinker, n (%) 203 (23) 198 (20) 94 (22) 75 (20) .060 .162 .075 .102 .301 .129
Estimated WL (%), mean (SD) 14.9 (5.9) 11.5 (6.5) 10.3 (4.6) 10.8 (4.3) < .001 < .001 < .001 .047 .080 .200
Estimated WL (Kg), mean (SD) 10.4 (4.0) 8.1 (4.2) 7.2 (3.1) 7.6 (2.9) < .001 < .001 < .001 .039 .095 .217
Baseline evaluation, n (%)
Accompanying symptoms 547 (62) 763 (77) 13 (3) 30 (8) < .001 < .001 < .001 < .001 < .001 .042
PE abnormalities 424 (48) 367 (37) 5 (1) 8 (2) < .001 < .001 < .001 < .001 < .001 .248
Lab. abnormalities 865 (98) 651 (66) 42 (10) 68 (18) < .001 < .001 < .001 < .001 < .001 < .001
Chest X-ray abnormalities 142 (16) 66 (7) 3 (1) 4 (1) < .001 < .001 < .001 < .001 < .001 .315
Normal baseline evaluation 4 (0) 55 (6) 364 (85) 272 (73) < .001 < .001 < .001 < .001 < .001 < .001
Time-to-diagnosis (days), mean (SD) * 14.6 (3.1) 15.4 (3.3) 12.3 (2.5) na. .057 < .001 na. < .001 na. na.
MDs, malignant disorders; NMDs, nonmalignant organic disorders; PSDs, psychosocial disorders; UE, initially unexplained unintentional weight loss; SE,
socioeconomic; PT, professional training; WL, weight loss; PE, physical examination; Lab., laboratory; na., not applicable.
* Initially unexplained unintentional weight loss is excluded.
Missing data: variables ‘no schooling’ (n = 2 in MDs and 1 in NMDs) and monthly incomes of’ ‘901–1200’
(n = 4 in MDs, 3 in NMDs, and 1 in PSDs) and of ‘1201–1800’ (n = 5 in MDs, 5 in NMDs, and 2 in UE).
https://doi.org/10.1371/journal.pone.0175125.t003
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Table 4. Characteristics according to age.*†
Characteristic <65 years 65 years P value
(n = 1258) (n = 1419)
Sex, n (%) .046
Females 634 (50) 670 (47)
Males 624 (50) 749 (53)
Socioeconomic status
Educational level, n (%) .106
No schooling 125 (10) 127 (9)
Primary or lower secondary 504 (40) 539 (38)
Upper secondary or professional training 424 (34) 525 (37)
University 203 (16) 227 (16)
Monthly household income (Euros), n (%) .067
900 118 (9) 156 (11)
901–1200 331 (26) 478 (34)
1201–1800 466 (37) 518 (37)
>1800 335 (27) 255 (18)
Current smoker, n (%) 347 (28) 426 (30) .079
Current drinker, n (%) 262 (21) 308 (22) .124
Age-adjusted Charlson comorbidity index (score), mean (SD) 2.4 (1.2) 4.9 (1.8) < .001
Estimated weight loss (% over 6–12 months), mean (SD) 10.7 (6.6) 13.1 (7.2) < .001
Estimated weight loss (Kg over 6–12 months), mean (SD) 7.5 (4.4) 9.1 (5.1) < .001
Unintentional weight loss of known origin, n (%) 1121 (89) 1181 (83) < .001
Malignant disorders 390 (31) 493 (35) < .001
Digestive malignancies [C15, C16, C18, C20, C25, C22.0, C22.1] 170 (14 [44]) 245 (17 [50]) .032
Other nonhematologic malignancies [C50, C53, C54.1, C56, C61, C64, C65, C66, C67, C34, C80.0] 144 (11 [37]) 227 (16 [46]) < .001
Hematologic malignancies [C81, C85.9] 76 (6 [19]) 21 (1 [4]) < .001
Nonmalignant organic disorders 479 (38) 512 (36) .072
Digestive disorders 191 (15) 259 (18) .040
Oral/swallowing/dental problems [R13, K11.7, K08.9, R43.8] ‡ 20 (2 [10]) 121 (9 [47]) < .001
Noninfective colitis/gastroenteritis [K52.3, K52.8] 58 (5 [30]) 39 (3 [15]) .090
Chronic vascular intestinal disorders [K55.1] 2 (0 [1]) 22 (2 [8]) .039
Other digestive disorders [K25, K26, K50, K51, K90.0, K90.3, K90.9] 111 (9 [58]) 77 (5 [30]) < .001
Endocrine disorders [E05, E06.1, E10, E11, E21.0] 106 (8) 33 (2) < .001
Infectious diseases 99 (8) 20 (1) < .001
Tuberculosis [A16.7, A16.5, A18.2, A16.3] 39 (3 [39]) 7 (0 [35]) .024
Human immunodeficiency virus [HIV] disease [B20, B21, B22.2] 24 (2 [24]) 2 (0 [10]) .028
Gastroenteritis/colitis [A09] 35 (3 [35]) 10 (1 [50]) .093
Infective endocarditis [I33.0] 1 (0 [1]) 1 (0 [5]) .203
Nervous system diseases 18 (1) 62 (4) .037
Stroke and Parkinson disease [I64, G20] 15 (1 [83]) 61 (4 [98]) .033
Motor neuron disease [G12.2] 3 (0 [17]) 1 (0 [2]) .199
Respiratory diseases [J84.1, J84.9, J90, J86.9, J85.2] 10 (1) 10 (1) .287
Systemic autoimmune diseases 26 (2) 63 (4) .072
Polymyalgia rheumatica/giant cell arteritis [M35.3, M31.5] 4 (0 [15]) 52 (4 [83]) < .001
Other autoimmune diseases [M30.0, M32.1†, M06.9] 22 (2 [85]) 11 (1 [17]) .136
Kidney and ureteral diseases [N01, N03, N04, N11.0, N11.1, N13.3] 26 (2) 14 (1) .140
Adverse effect of drugs [T88.7] 3 (0) 51 (4) < .001
Psychosocial disorders 252 (20) 176 (12) < .001
(Continued )
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psychosocial disorders (55%) than in nonmalignant organic disorders (39%), unexplained
UWL (35%), and malignancies (12%). Stable weight was more often in survivors with unex-
plained UWL (59%) than in nonmalignant organic disorders (51%), psychosocial disorders
(42%), and malignancies (22%) (Table 5).
Extended follow-up in patients with unexplained unintentional weight loss. Patients
with unexplained UWL were followed up for an initial period of 16.8 (6.9) months and an
additional period of 33.7 (9.4) months. The cumulative mean follow-up period (from initial
presentation) of the 375 patients with unexplained UWL was 47.5 (10.8) months (range, 1–65
months).
During the initial period (1–18 months), 18 patients died—16 shortly after hospitalization—
and 10 were lost to follow-up. Thirteen of 18 underwent autopsy. Specifically, autopsies were
performed in 10 patients with ongoing weight loss and in 3 in whom weight loss had stabilized.
All 13 autopsied patients died between 7 and 15 months after presentation. Postmortem ex-
amination revealed malignancies in 8 patients with slowly progressive, ongoing weight loss
including non-Hodgkin lymphoma in 4, metastatic melanoma in 3, and renal-cell carcinoma in
Table 4. (Continued)
Characteristic <65 years 65 years P value
(n = 1258) (n = 1419)
Depression/anxiety disorders/obsessive-compulsive disorder [F32, F45, F41, F42] 193 (15 [77]) 109 (8 [62]) < .001
Dementia [F00.9*, F01.9, F03] 5 (0 [2]) 42 (3 [24]) .019
Socioeconomic factors and immobility/disability problems [Z59, Z60, R26.3, Z73.6] 32 (3 [13]) 22 (2 [13]) .140
Other psychiatric disorders [F31, F20, F10, F11, F14, F19] 22 (2 [9]) 3 (0 [2]) .084
Initially unexplained unintentional weight loss, n (%) 137 (11) 238 (17) < .001
Time-to-diagnosis (days), mean (SD) 13.5 (3.4) 14.6 (3.5) .046
Follow-up
Follow-up time (months), mean (SD) 14.9 (7.8) 13.9 (7.0) .058
Deaths, n (%) 282 (22) 440 (31) < .001
* * Causes are categorized according to the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10 Version:
2015) [50]. Codes for specific disorders are detailed in Table 2.
† Relative percentages are shown in square brackets.
‡ R13: dysphagia and difficulty in swallowing, K11.7: disturbances of salivary secretion, K08.9: disorder of teeth and supporting structures, unspecified,
R43.8: other and unspecified disturbances of smell and taste [50].
Missing data: variables ‘no schooling’ (n = 2 in patients <65 years and n = 1 in patients65 years), monthly incomes of ‘901–1200’ (n = 3 in patients <65
years and n = 5 in patients65 years) and of ‘1201–1800’ (n = 5 in patients <65 years and n = 7 in patients65 years), and ‘age-adjusted Charlson
comorbidity index’ (n = 8 in patients <65 years and n = 11 in patients65 years).
https://doi.org/10.1371/journal.pone.0175125.t004
Table 5. Eighteen months’ outcomes of patient groups.
Outcome MDs a NMDs b PSDs c UE d P value
(n = 883) (n = 991) (n = 428) (n = 375) a vs. b a vs. c a vs. d b vs. c b vs. d c vs. d
Follow-up time (months), mean (SD) 9.7 (5.3) 16.2 (6.2) 17.3 (7.4) 16.8 (6.9) < .001 < .001 < .001 .077 .138 .216
Deaths, n (%) 612 (69) 61 (6) 21 (5) 18 (5) < .001 < .001 < .001 .172 .146 .274
Survivors with increased weight, n (%) 29/238 (12) 345/885(39) 205/373(55) 120/347 (35) < .001 < .001 < .001 < .001 .042 < .001
Survivors with decreased weight, n (%) 157/238 (66) 89/885(10) 11/373(3) 22/347(6) < .001 < .001 < .001 < .001 .031 .105
Survivors with stable weight, n (%) 52/238(22) 451/885(51) 157/373(42) 205/347(59) < .001 < .001 < .001 < .001 < .001 < .001
Lost to follow-up, n (%) 33 (4) 45 (5) 34 (8) 10 (3)
MDs, malignant disorders; NMDs, nonmalignant organic disorders; PSDs, psychosocial disorders; UE, initially unexplained unintentional weight loss.
https://doi.org/10.1371/journal.pone.0175125.t005
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1 along with massive pulmonary thromboembolism in 5 of them. There was no evidence of
malignancy in the remaining 5 autopsied patients. In addition, a likely underlying cause was
recognized in 4 additional patients with persistent weight loss including non-Hodgkin lym-
phoma in 2, metastatic melanoma in 1, and disseminated germ cell tumor in 1. All 4 patients
were diagnosed between 6 and 13 months after presentation. During the additional follow-up
period (18–66 months), 54 patients died—43 shortly after hospitalization—and 27 were lost to
follow-up. Twenty-four of 54 underwent autopsy between 18 and 28 months after presentation.
Necropsies were performed in 8 patients who had continued decreasing weight during the ini-
tial period and in whom weight loss continued during the additional period and in 16 patients
with stabilized weight in whom weight loss relapsed during the additional period. Examination
disclosed malignancies in 6 patients with slow, gradual weight loss including non-Hodgkin lym-
phoma in 3, metastatic melanoma in 1, renal-cell carcinoma in 1, and carcinoma of unknown
primary in 1. The remaining 18 patients did not have evidence of any malignancy at autopsy.
Lastly, 1 patient was diagnosed with Hodgkin lymphoma with exclusive bone marrow involve-
ment 19 months after presentation, at time of weight loss relapse following a 2 months’ period
of stabilization. Table 6 shows the characteristics of the 19 patients diagnosed with malignancy
during follow-up.
Discussion
We report here the largest prospective study of patients with UWL. While the main etiologies
of UWL agreed in general with previous reports, a salient finding of the study was the long
follow-up of patients with a diagnosis of unexplained UWL. During this period, the longest
reported up to now, several malignancies were detected in some living and, remarkably, de-
ceased patients at postmortem studies. Additionally, relevant differences were observed
between patients aged65 years and those aged<65 years. The sample sizes of the two groups
were large enough to establish solid comparisons, which may help further understand the
complex relationship between age and UWL.
With nearly 40% of UWL causes, nonmalignant organic disorders were the most frequent
etiologic group. Consistent with preceding reports [2–4,6,8,9], digestive disorders largely pre-
dominated in this group (45%). Of note, oral problems accounted for more digestive causes of
UWL than any other digestive condition—a factor linked to patient age (see below). Malignan-
cies were identified in one third of UWL patients and, also in line with reported evidence,
digestive malignancies prevailed (47%) [2,3,9,19], with pancreatic cancer comprising almost
20% of all malignancies. As expected [3,9], cancer patients were older, more often male, and
had more pronounced weight loss than other patients. While psychosocial disorders (princi-
pally depression) explained UWL in 16% of patients, an initial cause was not identified in 14%.
Although UWL has been extensively investigated in elders [1,10,11,15–18], studies have not
explicitly analyzed the differences between older and younger patients. Reports indicate that
15–20% of adults aged65 years have UWL [10,11] and that this prevalence is higher in com-
munity dwelling elders (27%) and nursing home residents (50–60%) [51]. Similar to the etiolo-
gies irrespective of age, malignancies, nonmalignant organic disorders, and psychosocial
disorders were the most common causes of UWL in older subjects in the current study. Ex-
pectedly, older patients had a higher occurrence of malignancies and specific nonmalignant
organic disorders than younger patients, including nervous system diseases, polymyalgia rheu-
matica with/without giant-cell arteritis, drug-induced UWL, and, predominantly, oral prob-
lems. The latter were only surpassed by nonhematologic malignancies as a cause of UWL.
While oral disorders made up 47% of digestive causes or 9% of all UWL causes in patients
aged65 years, the figures in younger patients were 10 and 2%, respectively.
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Several physiological and psychosocial factors may cause or contribute to UWL in elders.
Besides the decrease in lean body mass and bone mass with ageing, premature satiation due to
distorted gastric signals [52] and reduced senses of smell and taste [1] may produce lessened
interest in eating. Psychiatric disorders, particularly depression and dementia, have been
reported to be the main etiology of UWL in 10–20% of elders [10] and, in nursing home resi-
dents, this figure raises to 58% [53]. Depression, which has been more frequently associated
with weight loss in older subjects than in younger adults [54], or social isolation, disability/
immobility, and low income may cause weight loss due to anorexia and diminished motivation
(or feasibility) to buy and cook food [10,12,13]. Drugs and polypharmacy also represent a sig-
nificant etiologic factor of UWL [1,10–16]. In this study, prescribed and over-the-counter
Table 6. Characteristics of 19 patients diagnosed with cancer during follow-up.
Age
(yrs)








72 M None None Normal CT & FDG-PET None Necropsy 7 NHL
45 M None None Normal CT × 2 DVT RP mass Bx 13 GCT
68 F None Mild anemia Thrombocytosis Normal CT × 2 Normal BM
asp.
None Necropsy 9 RCC
70 M Sweating Mildly elevated LDH Normal CT × 3 & FDG-PET ×
2
None Necropsy 18 NHL
66 F None None Normal CT & FDG-PET None Necropsy 9 MM
68 F Low-grade fever &
sweating
Mildly elevated LDH & ESR Normal CT × 2 Fever BM Bx 6 NHL
63 M None None Normal CT & FDG-PET × 2 None Necropsy 8 MM
71 M None None Normal CT × 2 & FDG-PET None Necropsy 10 NHL
69 F None None Normal CT × 2 Axillary LDP LDP Bx 8 NHL
74 M None None Normal CT × 3 & FDG-PET ×
3
None Necropsy 21 RCC
64 F None None Normal CT × 2 & FDG-PET None Necropsy 7 MM
65 F None None Normal CT × 3 & FDG-PET ×
2
None Necropsy 19 MM
56 M None None Normal CT × 4 & FDG-PET ×
4
None Necropsy 28 CUP
69 F Splenomegaly None Normal CT × 3 & FDG-PET ×
3 Normal BM Bx
None Necropsy 15 NHL
66 M None None Normal CT & FDG-PET Lumbar
pain
Bone Bx 7 MM
67 M None Leukocytosis Elevated AST,
ALT & GGT
Normal CT × 3 & FDG-PET ×
2 Normal liver Bx
None Necropsy 18 NHL
73 F None None Normal CT × 3 & FDG-PET ×
3
Fever Necropsy 20 NHL
60 F Low-grade fever None Normal CT × 4 & FDG-PET ×
2
High fever BM Bx 19 HL
70 M None None Normal CT × 2 & FDG-PET None Necropsy 11 NHL
M, male; F, female; man., manifestations; lab., laboratory; abn., abnormalities; Dx, diagnostic; FU, follow-up; CT, computed tomography; FDG-PET,
fludeoxyglucose-positron emission tomography; NHL, non-Hodgkin lymphoma; DVT, deep vein thrombosis; RP, retroperitoneal; Bx, biopsy; GCT, germ cell
tumor; BM, bone marrow; asp., aspiration; RCC, renal-cell cancer; LDH, lactate dehydrogenase; MM, metastatic melanoma; ESR, erythrocyte
sedimentation rate; LDP, lymphadenopathy; CUP, carcinoma of unknown primary; AST, aspartate transaminase; ALT, alanine transaminase; GGT, gamma
glutamyl transpeptidase; HL, Hodgkin lymphoma.
* Other than weight loss.
† Time elapsed between initial presentation and definitive diagnosis.
https://doi.org/10.1371/journal.pone.0175125.t006
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drugs, alone or in combination, were the fundamental cause of UWL in 51 older patients (4%
of UWL causes) vs. 3 younger patients. A retrospective study in a US long-term care unit
showed that >75% of residents (mean age, 80 years) had been prescribed a drug that likely
contributed to weight loss [55]. Among other adverse effects, medications may affect cognition
and the subject faculty to eat, or induce xerostomia, anorexia, and nausea [10,56]. Oral prob-
lems can only worsen the situation, further contributing to UWL [10,11,15,16,57]. A study of
110 patients (mean age, 77 years) admitted to an US geriatric rehabilitation facility revealed
that the number of general oral problems was the strongest predictor of significant UWL
within 1 year prior to admission [58]. The prevalence of unexplained UWL in our work was
significantly higher in older than younger patients (17 vs. 11%). Despite substantial variations
in patients’ age, prospective and retrospective studies have shown that 16–28% of older pa-
tients remained without an identifiable cause of UWL after extensive investigations for up to
three years [2,4,6,8,10]. Arguably, this could be explained by the cumulative effects of several,
commonly interconnected, conditions (eg psychosocial issues, multimorbidity, underlying
frailty, oral disorders, polypharmacy, chronic pain) rather than by a serious organic disorder
[1,2,4,6–8,10,11,15].
The relevance of unexplained UWL deserves a separate consideration. The issue of unex-
plained UWL has prompted some amount of research. Based on the reported favorable out-
comes of patients with unexplained UWL with initially normal clinical evaluation, it has been
argued that a first negative screening with laboratory tests and chest X-ray is reassuring and
that serious ‘occult’ disorders, most notably cancer, escaping early detection and uncovered
during follow-up are extremely uncommon [1,2,4,8]. However, these claims rely on a few case
series with relatively small sample sizes, short or unspecified follow-up periods, and a near
total absence of autopsy examinations on dead patients [2–5,8].
A small number of studies have investigated unexplained UWL. In a US prospective study,
1 of 32 (3%) patients was diagnosed with cancer during 1 year of follow-up after an initially
negative baseline evaluation [4]. In another study in 306 patients with UWL without specific
symptoms (so-called by the authors ‘isolated UWL’), a malignancy was diagnosed in 9 (3%),
including one case of pancreatic cancer identified at autopsy, after a follow-up of 1 year [3]. A
report in 101 UWL patients disclosed no malignancy among those with unexplained UWL
(28%) and a normal baseline evaluation after a follow-up of 9.0 (6.8–16) months [2]. Yet no
autopsy was made in any patient who died during the follow-up. Lastly, in the only study to
date with the longest follow-up time (mean, 22 [7] months; range, 12–36 months), 26 (16%) of
158 cases were categorized as unexplained UWL [8]. While nonmalignant causes were uncov-
ered in 6 patients during follow-up, the follow-up time was not specified. Also, no deceased
patient with unexplained UWL underwent postmortem examination [8]. In the present report,
while 375 patients were initially categorized with unexplained UWL, malignancies were
detected in 19 of them (5% of cases of unexplained UWL) by extending the initial follow-up
period (ie up to 18 months after presentation) an additional 47 months. Overall, all later malig-
nancies were diagnosed between 6 and 28 months after referral, with 9 of 19 being identified
more than 12 months after it. Of note, the diagnosis was established postmortem in 14 of the
19 patients. Weight loss in patients with ‘occult’ cancers persisted from presentation in all but
1 case, in which it relapsed after a period of stabilization.
The study has some limitations. First, in addition to the conceivably different aptitudes and
attitudes of physicians evaluating UWL, clinical settings, inclusion and definition criteria, and
epidemiological and demographic characteristics of evaluable patients may differ substantially.
Therefore, the implications of the current study cannot be directly extrapolated to other set-
tings and generalized, which constitutes an inherent limitation. Second, the exclusion of
patients lost to follow-up (Fig 1) could potentially introduce bias to the results and subsequent
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conclusions. While the same might be true for missing data, its minimal extent and nature (ie
educational level, monthly income, and Charlson comorbidity index) meant that it was unlikely
to affect the results. Third, the long time elapsed in numerous cases between presentation and
diagnosis of malignancy was intriguing, mainly considering the lack of relevant abnormalities
of repeated tests, predominantly computed tomography and FDG-PET scanning (Table 6).
Although 4 patients had some abnormal laboratory tests, these were rather unspecific. The dis-
criminatory utility of laboratory tests for the diagnosis of cancer was found to be modest in a
recent prospective study in 290 patients with UWL [19]. However, several reports have con-
cluded that an organic disorder is unlikely when physical examination and baseline tests are
normal or irrelevant [2,4,12,13]. It might be reasonable to assume that initially unexplained
UWL was causally related to the later malignancies in the minority of patients who had this diag-
nosis beyond 12 months after referral (Table 6). Yet physiological evidence of a link between
UWL and subsequent occurrence of cancer was not available. Likewise, if losses to follow-up
and deaths without necropsy are excluded, 95% of patients with unexplained UWL did not have
a diagnosis of cancer throughout the full follow-up period (ie 66 months [5.5 years]). Thus, it is
possible that some of those who did have such a diagnosis developed it independently of UWL
(ie in a posterior stage), in which case there would be no causal link. However, the fact that 18
patients with late malignancies had persistent weight loss since presentation argues against this
possibility. Finally, since all apparently ‘occult’ cancers were uncovered (either in necropsy or in
living subjects) within 28 months after initial referral (Table 6), our approach of following
patients once every 3 months for 5 to 6 years may not have an additional advantage.
Our results have clinical implications. Based on the apparently exceptional occurrence of
‘hidden’ cancer and the favorable prognosis of patients with unexplained UWL who have a
negative baseline evaluation [2,4,5,8], it has been recommended a watchful waiting period of 1
to 6 months, while following-up patients for persistent weight loss and new manifestations
indicative of an ‘occult‘ disorder [1,2,12–14,59]. Although we agree with these recommenda-
tions, which otherwise rely on few and small case series with variable, mostly short, follow-ups,
appropriate follow-up periods have not been defined. Moreover, very few necropsies have been
done in reported patients with unexplained UWL dying during follow-up [2–4,8]. Based on our
findings, ‘occult‘ malignancies detected during a predefined follow-up of up to 66 months after
presentation do not seem to be as rare as thought. Nonetheless, the fact that only 1 in 20 patients
received such a diagnosis within this period, most notably within the first 28 months after refer-
ral for workup, is fairly reassuring. Cancer evading early diagnosis constitute a major concern.
In general, the prognosis of malignancies in patients presenting with UWL is very poor with
high mortality rates at the short-term because of frequently metastasizing disease when weight
loss becomes ostensible [1–3,8,14]. Therefore, despite a normal evaluation and workup and an
undisclosed etiology within 1 to 6 months after presentation, evaluation should continue for
periods longer than those reported so far through regular follow-up consultations. Furthermore,
in order to advance the understanding of unexplained UWL, postmortem studies should be
actively pursued in dead patients. In our study, 37 patients who died during follow-up under-
went autopsy but 35 did not. Lastly, older patients in whom an obvious cause of UWL is not
initially identified should not only be asked about subjective oral difficulties but a careful inspec-
tion of the oral cavity should be systematically performed as well as a videofluoroscopy or a
swallowing study if the oral examination does not yield conclusive results.
Conclusion
Among 2677 patients prospectively enrolled over 2 and a half years after referral to a diagnosis
clinic of an academic hospital in Barcelona for evaluation of UWL and who underwent a
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systematic baseline and follow-up approach, 37% were diagnosed with nonmalignant organic
disorders, 33% with malignancies, and 16% with psychosocial disorders. Significant differences
were observed according to patient age, with oral disorders being the second cause of UWL in
patients aged65 years—only after nonhematologic cancers. Of note, while 375 patients were
initially diagnosed with unexplained UWL (14% of whole population) because a cause could
not be recognized within the first 6 months, ‘hidden’ malignancies were detected in only 19 of
them during an extensive follow-up of up to 5.5 years after presentation, with all cases being
diagnosed within 28 months after it. Importantly, diagnosis was established at necropsy in 14
cases. Therefore, although unexplained UWL is only rarely a cause for short-term medical
alarm, serious underlying disease may be undetectable until death and, consequently, these
patients should indeed be followed up regularly (eg annual visits).
In summary, the results in this large cohort of patients with UWL provide new information
on the significance of follow-up in the long-term outcome of unexplained cases and on the
role of patient age on this clinical entity.
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